toosendanin has been researched along with Hepatitis C in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azuma, S; Funaoka, Y; Itsui, Y; Kakinuma, S; Kitazume, A; Kiyohashi, K; Murakawa, M; Nakagawa, M; Nishimura-Sakurai, Y; Nitta, S; Oooka, S; Sakamoto, N; Tsuchiya, K; Ueyama, M; Watanabe, M; Watanabe, T | 1 |
1 other study(ies) available for toosendanin and Hepatitis C
| Article | Year |
|---|---|
Inhibitory effect of a triterpenoid compound, with or without alpha interferon, on hepatitis C virus infection.
Topics: Antiviral Agents; Cell Line, Tumor; Drug Therapy, Combination; Drugs, Chinese Herbal; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; RNA, Viral; Virus Replication | 2011 |